4461 Share Price | DKS Co., Ltd. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

111.9 k

Shareholding (Dec 2011)

FII

0.03%

Held by 1 FIIs

DII

99.97%

Held by 0 DIIs

Promoter

0.00%

Compare DKS Co., Ltd. with Similar Stocks

Arakawa Chemical Industries Ltd.Harima Chemicals Group, Inc.Parker Corp.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

With a growth in Operating Profit of 20.38%, the company declared Very Positive results in Jun 25

The company has declared positive results for the last 6 consecutive quarters
DEBT-EQUITY RATIO (HY) Lowest at 37.34 %
NET SALES(Q) Highest at JPY 19,046 MM
NET PROFIT(Q) Highest at JPY 984 MM

With ROCE of 10.31%, it has a very attractive valuation with a 1.01 Enterprise value to Capital Employed

Market Beating performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Specialty Chemicals

Market cap

JPY 96,373 Million (Small Cap)

P/E

10.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.19

Return on Equity

10.26%

Price to Book

2.07

Revenue and Profits:

Net Sales:

18,984 Million

(Quarterly Results - Mar 2025)

Net Profit:

1,009 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

306.91%

6 Months

176.86%

1 Year

175.47%

2 Years

515.51%

3 Years

390.37%

4 Years

220.18%

5 Years

122.56%

DKS Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

3.57%

EBIT Growth (5y)

5.19%

EBIT to Interest (avg)

14.40

Debt to EBITDA (avg)

2.72

Net Debt to Equity (avg)

0.34

Sales to Capital Employed (avg)

0.98

Tax Ratio

26.43%

Dividend Payout Ratio

37.04%

Pledged Shares

Institutional Holding

0.03%

ROCE (avg)

6.73%

ROE (avg)

7.07%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.01

EV to EBIT

9.77

EV to EBITDA

6.10

EV to Capital Employed

1.01

EV to Sales

0.71

PEG Ratio

0.07

Dividend Yield

0.03%

ROCE (Latest)

10.31%

ROE (Latest)

10.55%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

No Trend

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2011

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.03%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 0.76% vs 5.25% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 7.45% vs -6.75% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "18,984.00",
          "val2": "18,840.00",
          "chgp": "0.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,356.00",
          "val2": "2,140.00",
          "chgp": "10.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "57.00",
          "val2": "64.00",
          "chgp": "-10.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-365.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,009.00",
          "val2": "939.00",
          "chgp": "7.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "81.50%",
          "val2": "70.50%",
          "chgp": "1.10%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 16.06% vs -3.02% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 132.64% vs 3,451.02% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "73,255.00",
          "val2": "63,118.00",
          "chgp": "16.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8,575.00",
          "val2": "5,294.00",
          "chgp": "61.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "260.00",
          "val2": "295.00",
          "chgp": "-11.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-365.00",
          "val2": "-66.00",
          "chgp": "-453.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,820.00",
          "val2": "1,642.00",
          "chgp": "132.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "73.10%",
          "val2": "32.90%",
          "chgp": "4.02%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ

Mar'25

Dec'24

Change(%)

Net Sales

18,984.00

18,840.00

0.76%

Operating Profit (PBDIT) excl Other Income

2,356.00

2,140.00

10.09%

Interest

57.00

64.00

-10.94%

Exceptional Items

-365.00

0.00

Consolidate Net Profit

1,009.00

939.00

7.45%

Operating Profit Margin (Excl OI)

81.50%

70.50%

1.10%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2025 is 0.76% vs 5.25% in Dec 2024

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2025 is 7.45% vs -6.75% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

73,255.00

63,118.00

16.06%

Operating Profit (PBDIT) excl Other Income

8,575.00

5,294.00

61.98%

Interest

260.00

295.00

-11.86%

Exceptional Items

-365.00

-66.00

-453.03%

Consolidate Net Profit

3,820.00

1,642.00

132.64%

Operating Profit Margin (Excl OI)

73.10%

32.90%

4.02%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 16.06% vs -3.02% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 132.64% vs 3,451.02% in Mar 2024

All Annual Results

Company CV

About DKS Co., Ltd.

DKS Co., Ltd.

Specialty Chemicals

No Details Available.

Company Coordinates

No Company Details Available